Quantum Genomics Société Anonyme (EPA:ALQGC)
France
· Delayed Price · Currency is EUR 0.0721
0.00 (0.00%)
Oct 24, 2024, 5:35 PM CET
EPA:ALQGC Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2014 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2014 - 2018 |
| Operating Revenue | - | 0.01 | 0.6 | 3.14 | 1.83 | - | Upgrade
|
| Other Revenue | 0 | 0.01 | 1.91 | 2.66 | 2.15 | 1.55 | Upgrade
|
| Revenue | 0 | 0.02 | 2.52 | 5.8 | 3.98 | 1.55 | Upgrade
|
| Revenue Growth (YoY) | -99.91% | -99.21% | -56.64% | 45.84% | 157.08% | 41869.61% | Upgrade
|
| Cost of Revenue | 1.43 | 1.44 | 29.5 | 18.27 | 14.54 | 7.57 | Upgrade
|
| Gross Profit | -1.43 | -1.42 | -26.99 | -12.47 | -10.56 | -6.02 | Upgrade
|
| Selling, General & Admin | 0.76 | 1.58 | 2.74 | 4.31 | 3.97 | 3.69 | Upgrade
|
| Other Operating Expenses | 0.07 | 0.13 | 0.09 | 0.29 | 0.02 | 0.01 | Upgrade
|
| Operating Expenses | 0.83 | 1.72 | 3.1 | 4.99 | 4.13 | 3.85 | Upgrade
|
| Operating Income | -2.27 | -3.14 | -30.08 | -17.45 | -14.68 | -9.87 | Upgrade
|
| Interest Expense | -0.02 | -0.02 | -0.02 | -0.04 | -0.01 | -0.01 | Upgrade
|
| Interest & Investment Income | - | - | 0 | 0.01 | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | -0 | -0.05 | -0.01 | -0.01 | Upgrade
|
| Other Non Operating Income (Expenses) | -6.83 | 0.25 | -0.38 | 0.36 | -1.44 | 0.01 | Upgrade
|
| EBT Excluding Unusual Items | -9.12 | -2.91 | -30.48 | -17.19 | -16.14 | -9.89 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.13 | -0 | -0.04 | - | - | - | Upgrade
|
| Asset Writedown | -0.14 | -0.26 | -0.28 | - | - | - | Upgrade
|
| Other Unusual Items | -0.06 | -0.03 | 3.32 | - | - | - | Upgrade
|
| Pretax Income | -9.44 | -3.21 | -27.48 | -17.19 | -16.14 | -9.89 | Upgrade
|
| Income Tax Expense | -0.03 | -0.03 | -2.55 | 0.17 | 0.08 | - | Upgrade
|
| Net Income | -9.4 | -3.17 | -24.94 | -17.36 | -16.22 | -9.89 | Upgrade
|
| Net Income to Common | -9.4 | -3.17 | -24.94 | -17.36 | -16.22 | -9.89 | Upgrade
|
| Shares Outstanding (Basic) | 70 | 35 | 35 | 27 | 20 | 17 | Upgrade
|
| Shares Outstanding (Diluted) | 70 | 35 | 35 | 27 | 20 | 17 | Upgrade
|
| Shares Change (YoY) | 100.00% | 0.01% | 29.17% | 32.20% | 21.63% | 6.39% | Upgrade
|
| EPS (Basic) | -0.13 | -0.09 | -0.72 | -0.64 | -0.79 | -0.59 | Upgrade
|
| EPS (Diluted) | -0.13 | -0.09 | -0.72 | -0.64 | -0.79 | -0.59 | Upgrade
|
| Free Cash Flow | - | - | -20.21 | -17.06 | -12.4 | -10.54 | Upgrade
|
| Free Cash Flow Per Share | - | - | -0.58 | -0.63 | -0.61 | -0.63 | Upgrade
|
| Gross Margin | - | - | - | -214.93% | -265.48% | - | Upgrade
|
| Operating Margin | -11936784.21% | -15847.91% | -1196.12% | -300.88% | -369.22% | -638.20% | Upgrade
|
| Profit Margin | -49478810.53% | -16018.12% | -991.45% | -299.29% | -407.95% | -639.04% | Upgrade
|
| Free Cash Flow Margin | - | - | -803.67% | -294.17% | -311.89% | -681.58% | Upgrade
|
| EBITDA | -2.01 | -2.87 | -29.82 | -17.19 | -14.67 | -9.86 | Upgrade
|
| EBITDA Margin | - | - | - | -296.31% | - | - | Upgrade
|
| D&A For EBITDA | 0.26 | 0.26 | 0.26 | 0.27 | 0.01 | 0.01 | Upgrade
|
| EBIT | -2.27 | -3.14 | -30.08 | -17.45 | -14.68 | -9.87 | Upgrade
|
| Revenue as Reported | 0.01 | 0.04 | 3.02 | - | - | - | Upgrade
|
Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.